ArticleBMJ open2016

Live cumulative network meta-analysis: protocol for second-line treatments in advanced non-small-cell lung cancer with wild-type or unknown status for epidermal growth factor receptor.

Perrine Créquit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.